Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Geneham Pharmaceutical is a specialized pharmaceutical company based in Changsha, China, focusing on the research, development, and production of high-purity natural plant extracts and active pharmaceutical ingredients (APIs). The company is recognized as a leading global supplier of Huperzine A, a sesquiterpene alkaloid primarily used for treating Alzheimer's disease and enhancing cognitive function. Their extensive product portfolio also includes L-Dopa, 5-HTP, and various other botanical derivatives tailored for the pharmaceutical, nutraceutical, and cosmetic sectors. Geneham operates state-of-the-art, GMP-compliant manufacturing facilities that utilize advanced extraction and purification technologies. The company maintains a strong commitment to quality control, ensuring that its natural products meet international standards for purity and safety.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Geneham Pharmaceutical.